GenoSpace Joins Thomson Reuters Life Sciences Partner Ecosystem
(Thomson Reuters ONE) -
Partnership to deliver solution for analyzing and interpreting human genomic
variations
PHILADELPHIA, PA, August 14, 2012 - The Intellectual Property & Science business
of Thomson Reuters, the world's leading provider of intelligent information for
businesses and professionals, today announced that GenoSpace joined its Life
Sciences Partner Ecosystem. The companies will work together to develop an
integrated product offering for the analysis and interpretation of human genomic
variation.
The GenoSpace platform seeks to establish secure, cloud-based online communities
and customized research portals that connect physicians, individuals, and
researchers who are interested in using clinical and genomic information; as
well as to provide analysis and interpretation tools that support personalized
medicine. An essential part of this process will be the detection and annotation
of gene variants. Thomson Reuters is in the unique position to collect, annotate
and publish a gene variant database and will work with GenoSpace to make this
data available to its customers.
Through the Thomson Reuters Life Sciences Partner Ecosystem, the GenoSpace
platform will provide access to an unprecedented amount of curated, medically
relevant data - from pathway and disease biology to regulatory and financial
information. The combination of GenoSpace's expertise in integrating clinical
and complex -omics data, coupled with the proven history of manual curation of
complex data by Thomson Reuters, the partnership will help enable the
realization of personalized medicine. Thomson Reuters and GenoSpace will produce
a curated database of genomic variation, with an emphasis on medical and
scientific utility.
"The barrier to establishing personalized medicine is no longer generating data,
but analyzing and interpreting it," said John Quackenbush, GenoSpace's CEO. "By
coupling our technology to synthesize genomic and clinical data with the
unparalleled information resources that Thomson Reuters has created, we are
positioned to lead the implementation of personalized medicine."
"We are delighted to welcome GenoSpace to our Partner Ecosystem," said Joseph
Donahue, senior vice president at Thomson Reuters. "Together, we will be able to
provide hospitals, health systems, disease foundations and pharmaceutical
research organizations with large scale clinical genomic data sets and tools to
help in annotating and interpreting genomic variation and support better
informed medical treatment decisions".
About GenoSpace
GenoSpace, LLC, is a Cambridge, Massachusetts-based company that is pioneering a
bold and innovative software platform for advancing 21st-century genomic
medicine. Founded in 2011 on the principle that individuals should own and
control access to their own genomic data, GenoSpace has built a robust software
system for securely storing vast amounts of genomic data and making it available
to individuals and groups who need to connect with each other and share data.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for
businesses and professionals. We combine industry expertise with innovative
technology to deliver critical information to leading decision makers in the
financial and risk, legal, tax and accounting, intellectual property and science
and media markets, powered by the world's most trusted news organization. With
headquarters in New York and major operations in London and Eagan, Minnesota,
Thomson Reuters employs approximately 60,000 people and operates in over 100
countries. For more information, go to www.thomsonreuters.com.
CONTACT
Laura Gaze
Thomson Reuters, Intellectual Property & Science
laura.gaze(at)thomsonreuters.com
+1 203 868 3340
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
[HUG#1633796]
Unternehmensinformation / Kurzprofil:
Datum: 14.08.2012 - 15:08 Uhr
Sprache: Deutsch
News-ID 174449
Anzahl Zeichen: 4717
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 183 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GenoSpace Joins Thomson Reuters Life Sciences Partner Ecosystem"
steht unter der journalistisch-redaktionellen Verantwortung von
Thomson Reuters Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
